Active Ingredients

Atrozemb® 10/10mg:

Each Film Coated Tablet contains Atorvastatin calcium trihydrate 10.82mg Equivalent to Atorvastatin 10mg + Ezetimibe 10mg.

Atrozemb® 20/10mg:

Each Film Coated Tablet contains Atorvastatin calcium trihydrate 21.64mg equivalent to Atorvastatin 20mg + Ezetimibe 10mg.

 

Indications

a-  Primary Hyperlipidemia:

       Atrozemb® is indicated for the reduction of elevated total cholesterol (total-C), low-density lipoprotein cholesterol

       (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and non-high-density lipoprotein cholesterol (non-HDL-C), and to

       increase high-density lipoprotein cholesterol (HDL-C) in patients with primary (heterozygous familial and non-familial)

       hyperlipidemia or mixed hyperlipidemia.

 

b- Homozygous Familial Hypercholesterolemia (HoFH):

       Atrozemb® is indicated for the reduction of elevated total-C and LDL-C in patients with homozygous familial

       hypercholesterolemia, as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or if such treatments are

       unavailable.

Mechanism of Action

-Atorvastatin:

         Competitive inhibition of HMG CoA reductase, the rate-limiting step in cholesterol synthesis.

- Ezetimibe:

         Selectively inhibits absorption of dietary and biliary cholesterol in the small intestine.

 

Dosage and Method of Usage

One film coated tablet to be taken orally once daily

Package and Storage

Carton box containing

3 Alu/Alu Blisters each of 10 tablets & insert leaflet

Atrozemb 20/10mg

• Keep out of reach of children

• Store below 30°C in a dry place

Storage Instructions

Carton box containing

3 Alu/Alu Blisters each of 10 tablets & insert leaflet

Atrozemb 10/10mg

All Rights Reserved Liptis Pharmaceuticals 2021